Precision Therapy Versus Standard Therapy in AML and MDS in Elderly

NCT05025098 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult
MDS

Interventions

DRUG: Standard therapy
DRUG: Precision therapy

Sponsor

University Hospital, Akershus